Potassium-Competitive Acid Blocker Versus pROton-Pump Inhibitor for GastroproTECTion Strategies In Patients at High Gastro-Intestinal Bleeding Risk Receiving Antithrombotic Therapy | MicrobiomeTrials
Potassium-Competitive Acid Blocker Versus pROton-Pump Inhibitor for GastroproTECTion Strategies In Patients at High Gastro-Intestinal Bleeding Risk Receiving Antithrombotic Therapy
RecruitingPHASE4INTERVENTIONAL
Trial Details
Start: 2021-05-12Est. Completion: 2027-12-31
Enrollment target: 3,320 participants
Locations
Hallym University Sacred Heart Hospital, Anyang, South Korea
Bucheon Sejong Hospital, Bucheon-si, South Korea
Kosin University Gospel Hospital, Busan, South Korea
Gyeongsang National University Changwon Hospital, Changwon, South Korea
Sungkyunkwan University Samsung Changwon Hospital, Changwon, South Korea
Dankook University Hospital, Cheonan, South Korea
Chungbuk National University Hospital, Cheonju, South Korea
Gangwon National Univ. Hospital, Chuncheon, South Korea
Hallym University Chuncheon Sacred Heart Hospital, Chuncheon, South Korea
Keimyung University Dongsan Medical Center, Daegu, South Korea
Yeungnam University Medical Center, Daegu, South Korea
Chungnam National University Hospital, Daejeon, South Korea
Gangneung Asan Hospital, Gangneung, South Korea
Hanyang University Guri Hospital, Guri-si, South Korea
Chonnam National University Hospital, Gwangju, South Korea
Hallym University Dongtan Sacred Heart Hospital, Hwaseong-si, South Korea
Other microbiome trials you might be interested in